MedTrace Logo

CXCL10 As a Biomarker Of ILD in Patients WithRA

NCT04356066 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-04-22

No results posted yet for this study

Summary

Rheumatoid arthritis is a chronic inflammatory disease that affects the joints, causing symmetric pain, stiffness, swelling, and limited motion and function of multiple joints, its fibro inflammatory manifestations may develop in other organs.

Conditions

  • Interstitial Lung Disease in Patients With Rheumatoid Arthritis

Interventions

DIAGNOSTIC_TEST

serum cxcl10 by ELISA

serum sample

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-19
Primary Completion
2021-01-19
Completion
2022-01-19

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04356066 on ClinicalTrials.gov